{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    19,
    20,
    21,
    22,
    23,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Upadacitinib",
        "type": {
          "id": "a2aa3d5f-5f0a-4049-8e60-669d42a0b08e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "4e9c0954-e984-4a7d-a5aa-668206628a23",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Selective JAK1 inhibitor for the treatment of active psoriatic arthritis.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "6729651f-e4ff-40c0-bd25-76608aec0e7c",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "17cb8c69-8eeb-43c1-9f48-97a7bf4971c2",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo for upadacitinib.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Methotrexate (MTX)",
        "type": {
          "id": "297a842d-cd60-4692-bbaa-b014bc1bfde2",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "85831043-2e2c-468c-b362-226f7d9a929f",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 25 mg/week.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Sulfasalazine (SSZ)",
        "type": {
          "id": "3f7ddc42-7ee9-4c6b-b6f9-051f1fdf86f7",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "fe268841-ddaa-4541-9927-12733685beda",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 3000 mg/day."
      },
      {
        "id": "int_5",
        "name": "Leflunomide (LEF)",
        "type": {
          "id": "9159a514-b897-4467-bf24-029dea652452",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "b35bdf4b-8ebd-4616-9e50-281b6da35def",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 20 mg/day."
      },
      {
        "id": "int_6",
        "name": "Apremilast",
        "type": {
          "id": "3f069a32-a3bd-4c22-b16b-ae318c0a03d3",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "0c75026f-3b57-48c5-a5d7-e76baf8e708a",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 60 mg/day."
      },
      {
        "id": "int_7",
        "name": "Hydroxychloroquine (HCQ)",
        "type": {
          "id": "5849507e-d65f-4c9c-a3be-6aa456a48c96",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "78bd9b17-24b4-41b5-9544-23005adafef2",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 400 mg/day."
      },
      {
        "id": "int_8",
        "name": "Bucillamine",
        "type": {
          "id": "f20f340b-546c-46b3-912c-84abc38144d3",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "db916f14-2be8-4cf4-96a8-f2562700b4b8",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 300 mg/day."
      },
      {
        "id": "int_9",
        "name": "Iguratimod",
        "type": {
          "id": "9e58de57-33f9-4753-b7d5-60b19cf6156f",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "9468ca02-1c27-4a71-b453-dc3b6afc3be5",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 50 mg/day."
      },
      {
        "id": "int_10",
        "name": "Folic acid",
        "type": {
          "id": "324e662e-7801-4660-ae77-ced72d3c7e69",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "18cc0150-b2d5-48cd-adc3-ecfaf118f5ee",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required dietary supplement for all subjects taking MTX."
      },
      {
        "id": "int_11",
        "name": "NSAIDs",
        "type": {
          "id": "4c1a56ef-a47e-49f3-bc91-98df781512fa",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0e62d2aa-e925-4d5f-a38e-70627486b703",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
      },
      {
        "id": "int_12",
        "name": "Acetaminophen/paracetamol",
        "type": {
          "id": "d2721157-d665-4a58-8d67-577cc18c9c85",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8085123f-c7f2-41f8-a7c8-1114ded1ec56",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
      },
      {
        "id": "int_13",
        "name": "Oral corticosteroids",
        "type": {
          "id": "fdb9f370-0dc7-47ff-b3bc-46a400834f0a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "7fa7cdeb-da99-48cb-949e-07a08a8766e6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted at stable doses equivalent to prednisone ≤ 10 mg/day."
      },
      {
        "id": "int_14",
        "name": "Low-potency opiates",
        "type": {
          "id": "7994212b-977d-4f95-a2db-6ae969e2a05f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "ee52fa81-8d44-4a91-9ade-62222f5a4d1f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Tramadol or combination of acetaminophen and codeine/hydrocodone permitted."
      },
      {
        "id": "int_15",
        "name": "Intra-articular corticosteroid injection",
        "type": {
          "id": "7873dff6-61c3-4e42-9123-919c92913072",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "12ca04d7-b7f6-46c2-a746-b3990ba04523",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Offered to non-responders at Week 16 for one peripheral joint/site."
      },
      {
        "id": "int_16",
        "name": "Strong CYP3A inhibitors/inducers",
        "type": {
          "id": "eb6cb799-7b22-46b5-b7da-e6c40c5c5a57",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "6f91b9be-191a-4352-badc-205e2f41c1fc",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited from Screening through the last dose of study drug."
      },
      {
        "id": "int_17",
        "name": "Live vaccines",
        "type": {
          "id": "c83afd69-c199-4848-be1e-3cc6634639f2",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "5ecd7307-09e1-4c15-9416-41d260d91a5f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 4 weeks (8 weeks in Japan) prior to Baseline and during study."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Upadacitinib (ABT-494)",
        "administrableDoseForm": {
          "id": "79e2a528-b027-4c48-b3fb-2269a5ae04c4",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "65df22e1-8bac-4cf8-8cbd-047239cb27f0",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "beb3d7db-dc0e-4ac4-b46e-728505381fb1",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "15 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "AbbVie"
      },
      {
        "id": "prod_2",
        "name": "Upadacitinib (ABT-494)",
        "administrableDoseForm": {
          "id": "f432cc79-6284-4a59-abb1-74a56f64a20f",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "b9913805-966d-4d9e-bd48-a17441f12475",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "244aa2de-8cf1-4d68-89b0-c82a00779a70",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "30 mg",
        "manufacturer": "AbbVie"
      },
      {
        "id": "prod_3",
        "name": "Placebo",
        "administrableDoseForm": {
          "id": "f98b86cc-14f3-4371-9c0d-9493769e7b09",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "1735a361-f405-42ea-999e-2c319fd5221a",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "760a6303-ec64-4df6-9c5e-e05c52ceefc9",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Matching",
        "manufacturer": "AbbVie"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Upadacitinib 15 mg QD",
        "instanceType": "Administration",
        "dose": "15 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Up to approximately 3 years"
      },
      {
        "id": "admin_2",
        "name": "Upadacitinib 30 mg QD",
        "instanceType": "Administration",
        "dose": "30 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until Protocol Amendment 8 approval (then switched to 15 mg)"
      },
      {
        "id": "admin_3",
        "name": "Placebo QD",
        "instanceType": "Administration",
        "dose": "1 tablet",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "24 weeks"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Upadacitinib",
        "instanceType": "Substance",
        "description": "Janus Kinase (JAK) 1 inhibitor"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 17,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Upadacitinib",
        "role": "Investigational Product",
        "description": "Selective JAK1 inhibitor for the treatment of active psoriatic arthritis."
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo for upadacitinib."
      },
      {
        "name": "Methotrexate (MTX)",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 25 mg/week."
      },
      {
        "name": "Sulfasalazine (SSZ)",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 3000 mg/day."
      },
      {
        "name": "Leflunomide (LEF)",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 20 mg/day."
      },
      {
        "name": "Apremilast",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 60 mg/day."
      },
      {
        "name": "Hydroxychloroquine (HCQ)",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 400 mg/day."
      },
      {
        "name": "Bucillamine",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 300 mg/day."
      },
      {
        "name": "Iguratimod",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 50 mg/day."
      },
      {
        "name": "Folic acid",
        "role": "Concomitant Medication",
        "description": "Required dietary supplement for all subjects taking MTX."
      },
      {
        "name": "NSAIDs",
        "role": "Concomitant Medication",
        "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
      },
      {
        "name": "Acetaminophen/paracetamol",
        "role": "Concomitant Medication",
        "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
      },
      {
        "name": "Oral corticosteroids",
        "role": "Concomitant Medication",
        "description": "Permitted at stable doses equivalent to prednisone ≤ 10 mg/day."
      },
      {
        "name": "Low-potency opiates",
        "role": "Concomitant Medication",
        "description": "Tramadol or combination of acetaminophen and codeine/hydrocodone permitted."
      },
      {
        "name": "Intra-articular corticosteroid injection",
        "role": "Rescue Medication",
        "description": "Offered to non-responders at Week 16 for one peripheral joint/site."
      },
      {
        "name": "Strong CYP3A inhibitors/inducers",
        "role": "Concomitant Medication",
        "description": "Prohibited from Screening through the last dose of study drug."
      },
      {
        "name": "Live vaccines",
        "role": "Concomitant Medication",
        "description": "Prohibited within 4 weeks (8 weeks in Japan) prior to Baseline and during study."
      }
    ],
    "products": [
      {
        "name": "Upadacitinib (ABT-494)",
        "doseForm": "Tablet",
        "strength": "15 mg",
        "manufacturer": "AbbVie"
      },
      {
        "name": "Upadacitinib (ABT-494)",
        "doseForm": "Tablet",
        "strength": "30 mg",
        "manufacturer": "AbbVie"
      },
      {
        "name": "Placebo",
        "doseForm": "Tablet",
        "strength": "Matching",
        "manufacturer": "AbbVie"
      }
    ],
    "substances": [
      {
        "name": "Upadacitinib",
        "description": "Janus Kinase (JAK) 1 inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Upadacitinib 15 mg QD",
        "dose": "15 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "Up to approximately 3 years"
      },
      {
        "name": "Upadacitinib 30 mg QD",
        "dose": "30 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "Until Protocol Amendment 8 approval (then switched to 15 mg)"
      },
      {
        "name": "Placebo QD",
        "dose": "1 tablet",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "24 weeks"
      }
    ],
    "devices": []
  }
}